Drug Approval | August 16, 2023
Eugia Pharma receives USFDA Approval for Icatibant Injection
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
Fluocinolone Acetonide Oil (RLD Derma-Smoothe/FS®) had estimated annual sales of USD 10 million in the U.S. (IQVIA MAT June 2023)
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
This transformation will enable GE HealthCare to build a strong foundation for business growth
Chlorpromazine Hydrochloride Tablets USP had an estimated annual sale of USD 45 million in the U.S.
This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries
Cyanocobalamin Nasal Spray (RLD Nascobal) had estimated annual sales of USD 69 million in the U.S. (IQVIA MAT Mar 2023)
Subscribe To Our Newsletter & Stay Updated
